参天製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/03 | 1,269 | 1,270 | 1,251 | 1,268 | +9 | +0.7% | 878,800 |
| 2022/03/02 | 1,275 | 1,287 | 1,258 | 1,259 | -32 | -2.5% | 795,000 |
| 2022/03/01 | 1,304 | 1,315 | 1,291 | 1,291 | -13 | -1% | 935,800 |
| 2022/02/28 | 1,273 | 1,307 | 1,266 | 1,304 | +37 | +2.9% | 2,395,900 |
| 2022/02/25 | 1,254 | 1,275 | 1,250 | 1,267 | +20 | +1.6% | 1,282,300 |
| 2022/02/24 | 1,260 | 1,263 | 1,237 | 1,247 | -27 | -2.1% | 1,528,500 |
| 2022/02/22 | 1,281 | 1,286 | 1,265 | 1,274 | -10 | -0.8% | 992,000 |
| 2022/02/21 | 1,277 | 1,293 | 1,271 | 1,284 | -21 | -1.6% | 704,800 |
| 2022/02/18 | 1,275 | 1,311 | 1,274 | 1,305 | +12 | +0.9% | 876,400 |
| 2022/02/17 | 1,305 | 1,307 | 1,289 | 1,293 | -17 | -1.3% | 1,096,300 |
| 2022/02/16 | 1,315 | 1,324 | 1,302 | 1,310 | +6 | +0.5% | 1,132,600 |
| 2022/02/15 | 1,290 | 1,310 | 1,286 | 1,304 | +15 | +1.2% | 1,067,400 |
| 2022/02/14 | 1,303 | 1,313 | 1,283 | 1,289 | -45 | -3.4% | 1,948,700 |
| 2022/02/10 | 1,365 | 1,369 | 1,320 | 1,334 | -3 | -0.2% | 1,812,600 |
| 2022/02/09 | 1,333 | 1,348 | 1,322 | 1,337 | +9 | +0.7% | 846,600 |
| 2022/02/08 | 1,332 | 1,341 | 1,324 | 1,328 | +7 | +0.5% | 835,700 |
| 2022/02/07 | 1,314 | 1,327 | 1,311 | 1,321 | +2 | +0.2% | 651,100 |
| 2022/02/04 | 1,305 | 1,325 | 1,302 | 1,319 | +19 | +1.5% | 1,253,200 |
| 2022/02/03 | 1,291 | 1,305 | 1,287 | 1,300 | -7 | -0.5% | 1,151,600 |
| 2022/02/02 | 1,293 | 1,315 | 1,293 | 1,307 | +20 | +1.6% | 1,531,600 |
| 2022/02/01 | 1,313 | 1,313 | 1,287 | 1,287 | -10 | -0.8% | 1,239,300 |
| 2022/01/31 | 1,289 | 1,306 | 1,277 | 1,297 | +15 | +1.2% | 1,197,000 |
| 2022/01/28 | 1,274 | 1,285 | 1,267 | 1,282 | +4 | +0.3% | 1,578,000 |
| 2022/01/27 | 1,308 | 1,315 | 1,266 | 1,278 | -46 | -3.5% | 1,477,100 |
| 2022/01/26 | 1,327 | 1,332 | 1,308 | 1,324 | -10 | -0.7% | 1,087,900 |
| 2022/01/25 | 1,318 | 1,335 | 1,305 | 1,334 | +7 | +0.5% | 1,054,600 |
| 2022/01/24 | 1,284 | 1,327 | 1,283 | 1,327 | +38 | +2.9% | 1,474,000 |
| 2022/01/21 | 1,299 | 1,300 | 1,275 | 1,289 | -16 | -1.2% | 1,901,100 |
| 2022/01/20 | 1,301 | 1,320 | 1,300 | 1,305 | +4 | +0.3% | 1,595,500 |
| 2022/01/19 | 1,330 | 1,338 | 1,298 | 1,301 | -42 | -3.1% | 1,486,900 |
| 2022/01/18 | 1,380 | 1,383 | 1,340 | 1,343 | -37 | -2.7% | 1,530,700 |
| 2022/01/17 | 1,389 | 1,395 | 1,370 | 1,380 | -6 | -0.4% | 670,200 |
| 2022/01/14 | 1,403 | 1,414 | 1,378 | 1,386 | -46 | -3.2% | 1,602,200 |
| 2022/01/13 | 1,460 | 1,463 | 1,431 | 1,432 | -7 | -0.5% | 1,270,100 |
| 2022/01/12 | 1,437 | 1,457 | 1,435 | 1,439 | +12 | +0.8% | 1,396,200 |
| 2022/01/11 | 1,423 | 1,432 | 1,408 | 1,427 | +18 | +1.3% | 1,158,200 |
| 2022/01/07 | 1,417 | 1,425 | 1,401 | 1,409 | -6 | -0.4% | 854,800 |
| 2022/01/06 | 1,410 | 1,432 | 1,409 | 1,415 | -7 | -0.5% | 919,800 |
| 2022/01/05 | 1,421 | 1,431 | 1,416 | 1,422 | -10 | -0.7% | 1,074,600 |
| 2022/01/04 | 1,417 | 1,439 | 1,412 | 1,432 | +25 | +1.8% | 788,400 |
| 2021/12/30 | 1,410 | 1,416 | 1,403 | 1,407 | -10 | -0.7% | 733,400 |
| 2021/12/29 | 1,421 | 1,437 | 1,413 | 1,417 | -2 | -0.1% | 767,500 |
| 2021/12/28 | 1,406 | 1,420 | 1,402 | 1,419 | +17 | +1.2% | 675,000 |
| 2021/12/27 | 1,404 | 1,406 | 1,398 | 1,402 | -10 | -0.7% | 497,900 |
| 2021/12/24 | 1,418 | 1,418 | 1,405 | 1,412 | ±0 | ±0% | 623,900 |
| 2021/12/23 | 1,420 | 1,420 | 1,405 | 1,412 | +1 | +0.1% | 693,600 |
| 2021/12/22 | 1,415 | 1,419 | 1,405 | 1,411 | +3 | +0.2% | 1,191,100 |
| 2021/12/21 | 1,405 | 1,420 | 1,399 | 1,408 | +17 | +1.2% | 1,399,900 |
| 2021/12/20 | 1,388 | 1,397 | 1,383 | 1,391 | -7 | -0.5% | 1,228,800 |
| 2021/12/17 | 1,417 | 1,427 | 1,391 | 1,398 | -13 | -0.9% | 1,986,800 |
851～
900
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| ロート | 253,300円 | +8.4% | +6.4% | 1.66% | 18.17倍 | 2.20倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 住友ファーマ | 143,900円 | -11.0% | +206.6% | 0.00% | 14.29倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 久光薬 | 429,800円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 364,600円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム
